Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, No. 1-1, Seiryo-Machi, Aoba Ward, Sendai City 980-8574, Japan.
Department of Internal Medicine and Rehabilitation Science, Tohoku University Graduate School of Medicine, No. 1-1, Seiryo-Machi, Aoba Ward, Sendai City 980-8574, Japan.
Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. Epub 2014 Mar 24.
The Great East Japan earthquake and tsunami caused immense damage over a wide area of eastern Japan. Hence, many survivors are at high risk for posttraumatic stress disorder (PTSD). This randomized, observer-blinded, controlled trial examined the efficacy and safety of the traditional Japanese herbal formula saikokeishikankyoto (SKK) in the treatment of PTSD among survivors of this disaster. Forty-three participants with an Impact of Event Scale-Revised (IES-R) score ≥ 25 were randomized into SKK (n = 21) and control (n = 22) groups. The primary endpoint was the change in IES-R scores from baseline till after 2 weeks of treatment. Intergroup statistical comparisons were performed. The magnitude of changes in total IES-R scores differed significantly between the two groups (P < 0.001). Post hoc analysis showed that the total IES-R score improved significantly in the SKK group from 49.6 ± 11.9 to 25.5 ± 17.0 (P < 0.001). Subscale scores improved significantly in the SKK group (avoidance, P = 0.003; hyperarousal, P < 0.001; intrusion, P < 0.001). Two-week treatment with SKK significantly improved IES-R scores among PTSD patients. This traditional medicine may be a valid choice for the treatment of psychological and physical symptoms in PTSD patients.
东日本大地震和海啸在日本东部广大地区造成了巨大的破坏。因此,许多幸存者面临着创伤后应激障碍(PTSD)的高风险。这项随机、观察者盲法、对照试验研究了传统日本草药配方四君子汤(SKK)在治疗这场灾难幸存者 PTSD 中的疗效和安全性。43 名影响事件量表修订版(IES-R)得分≥25 的参与者被随机分为 SKK(n=21)和对照组(n=22)。主要终点是治疗 2 周后 IES-R 评分从基线的变化。进行了组间统计比较。两组总 IES-R 评分的变化幅度差异有统计学意义(P<0.001)。事后分析显示,SKK 组的总 IES-R 评分从 49.6±11.9 显著改善至 25.5±17.0(P<0.001)。SKK 组的子量表评分也显著改善(回避,P=0.003;警觉过度,P<0.001;闯入,P<0.001)。两周的 SKK 治疗显著改善了 PTSD 患者的 IES-R 评分。这种传统药物可能是 PTSD 患者治疗心理和身体症状的有效选择。